Deciding if, how and when to engage in an election campaign for an industry association like Medicines Australia probably is more art than science, says former Medicines Australia CEO Dr Brendan Shaw.

Latest Video
New Stories
-
Orthocell submits for Remplir regulatory approval in Thailand
February 24, 2025 - - Australian Biotech -
AdPha welcomes commitment to expand access to bulk-billing incentive
February 24, 2025 - - Latest News -
New Zealand medtech start-up Avasa hits milestone in development of world’s first arterial coupler
February 24, 2025 - - Other Health -
Neuren receives rare paediatric disease designation from the US FDA
February 24, 2025 - - Australian Biotech -
High profile Australians expose the painful reality of shingles in awareness week
February 24, 2025 - - Latest News -
Fix the language, accept the political discomfort it will cause, or forget about meaningful change
February 24, 2025 - - Latest News -
Ovarian Cancer Australia says new report highlights the need for action
February 24, 2025 - - Latest News